| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.36(B) |
| Last
Volume: |
660,191 |
Avg
Vol: |
495,679 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
52,026 |
112,537 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,659,768 |
$9,356,099 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
16 |
32 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simon Christopher |
President & CEO |
• • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
102,064 |
417,411 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-06-09 |
4 |
AS |
$97.19 |
$18,175 |
D/D |
(187) |
1,983 |
|
-4% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$66,660 |
D/D |
(687) |
16,376 |
|
5% |
|
| Simon Christopher |
President & CEO |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$283,328 |
D/D |
(2,920) |
315,347 |
|
5% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$62,002 |
D/D |
(639) |
12,695 |
|
5% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-06-08 |
4 |
AS |
$97.03 |
$117,647 |
D/D |
(1,189) |
2,170 |
|
-5% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-06-08 |
4 |
OE |
$41.64 |
$46,054 |
D/D |
1,106 |
3,276 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$31,438 |
D/D |
(324) |
5,714 |
|
5% |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,692 |
4,355 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
2,253 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-05-18 |
4 |
AS |
$101.72 |
$10,274 |
D/D |
(101) |
1,709 |
|
-10% |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
6,038 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,144 |
13,334 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,902 |
17,063 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,209 |
3,390 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
14,510 |
318,267 |
|
- |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$10,747 |
D/D |
(107) |
2,663 |
|
11% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-05-15 |
4 |
AS |
$100.44 |
$4,218 |
D/D |
(42) |
1,810 |
|
-11% |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$11,048 |
D/D |
(110) |
4,466 |
|
11% |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$22,197 |
D/D |
(221) |
10,190 |
|
11% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$20,389 |
D/D |
(203) |
14,161 |
|
11% |
|
| Simon Christopher |
President & CEO |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$101,244 |
D/D |
(1,008) |
303,757 |
|
11% |
|
| Coyle Michael J |
Director |
• • – |
2020-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
478 |
478 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2020-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,181 |
2,181 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2020-04-09 |
4 |
AS |
$102.00 |
$1,112,004 |
D/D |
(10,902) |
18,418 |
|
-15% |
|
1368 Records found
|
|
Page 11 of 55 |
|
|
0.92 (1.09%) 
